Now, a multi-institutional study by Rockefeller scientist W. Vallen Graham and colleagues points to a novel approach to managing IBD. Published in Nature Medicine, the study describes the discovery of a new compound that targets not the inflammation itself, but the leaky intestinal tracts that lead to inflammation in the first place.
https://www.rockefeller.edu/news/25514-new-approach-treating-gastrointestinal-disease-patches-leaky-intestines/